Strategies for retargeted gene delivery using vectors derived from lentiviruses.
about
Roles of RabGEF1/Rabex-5 domains in regulating Fc epsilon RI surface expression and Fc epsilon RI-dependent responses in mast cellsEpstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73αSilence of the transcripts: RNA interference in medicine.Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.Gene therapy progress and prospects: viral trafficking during infection.Viral gene therapy.Gene therapy progress and prospects: RNA aptamers.Stem cell therapy for inherited metabolic disorders of the liver.Retroviral proteins that interact with the host cell cytoskeletonNew methods for investigating experimental human adrenal tumorigenesis.Recent advances in hepatitis C virus cell entry.High-throughput transfection and engineering of primary cells and cultured cell lines - an invaluable tool for research as well as drug development.Lentivirus-Mediated Silencing of Myosin VI Inhibits Proliferation and Cell Cycle Progression in Human Lung Cancer Cells.Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer.Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticlesSustained, localized transgene expression mediated from lentivirus-loaded biodegradable polyester elastomers.Lentivirus-mediated sFlt-1 gene fragment transfer suppresses retinal neovascularization.Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.siRNA targeting TCTP suppresses osteosarcoma cell growth and induces apoptosis in vitro and in vivo.
P2860
Q24674977-94949B76-9228-4388-9FCE-5CD9D799852EQ28487983-004F2D34-2A5C-4639-8B6F-6819C535F333Q36199753-6505E03A-6F48-46CD-9235-9D794C9FA64AQ36248825-FC682C1A-6AF2-4DFC-910B-03E888E7B026Q36252999-43781033-85D6-4F3B-830B-E3359C88679BQ36684458-57F6167E-93AE-418C-A5C0-0AD628C1B7ABQ36728599-BE0CA3E4-ECF7-4E96-B988-85D794B1D7B9Q36744280-F3E880B8-12C6-4571-B2E6-23338AE58E4CQ36913964-F395BADD-18B4-4130-B2FD-780234CAB9A9Q37176993-A871FDA5-3146-4EE8-9AF7-F0AB692972B7Q37945199-9B54CE34-18EC-477B-B87D-57C548B77D4CQ38088746-0AFDA62C-92A9-4CB0-A849-5F3004587C48Q38913936-2EE34CD4-FD81-4BCE-8AE8-6F8CEB24F08CQ38956409-1981D405-83B9-4E72-B386-74258A60ECBFQ39893565-4718DD5F-A75B-4B36-8239-4D1E77E388C6Q40740910-9FF0D267-65E4-4558-A715-6524D5DBAD98Q46032731-CDC1E5C0-F94B-45D7-BBC6-BB6F87258878Q53544194-750E1E47-CF96-4EAB-91BC-94DC846C1C2BQ53664745-25DF9EE2-067D-4AD5-888C-FDC8B3BFF164
P2860
Strategies for retargeted gene delivery using vectors derived from lentiviruses.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Strategies for retargeted gene delivery using vectors derived from lentiviruses.
@ast
Strategies for retargeted gene delivery using vectors derived from lentiviruses.
@en
type
label
Strategies for retargeted gene delivery using vectors derived from lentiviruses.
@ast
Strategies for retargeted gene delivery using vectors derived from lentiviruses.
@en
prefLabel
Strategies for retargeted gene delivery using vectors derived from lentiviruses.
@ast
Strategies for retargeted gene delivery using vectors derived from lentiviruses.
@en
P356
P1433
P1476
Strategies for retargeted gene delivery using vectors derived from lentiviruses
@en
P2093
Francois-Loic Cosset
P304
P356
10.2174/1566523043345995
P407
P577
2004-12-01T00:00:00Z